Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Acta Endocrinol (Buchar) ; 14(3): 330-337, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-31149280

RESUMEN

INTRODUCTION: Childhood obesity is a public health problem characterized by early insulin resistance (IR), inflammation, and oxidative stress. The presence of an uninterrupted low-grade inflammatory state impairs metabolic and cardiovascular health. The population is particularly susceptible to develop metabolic disorders related to increased body fat. METHODS: Eighty-three adolescents were recruited and grouped according to HOMA-IR and BMI in either with or without IR and obese or normal-weight respectively. Anthropometric, biochemical, immunological and hormonal variables were determined. Transverse Analytical Study. RESULTS: Obesity, dyslipidemia, IL-6, and C-reactive protein were significantly higher in the IR group than in the non-IR group. Obese adolescents showed increased insulin levels, HOMA-IR, inflammatory markers, and triglycerides; while having lower HDL-C, and adiponectin when compared to normal-weight adolescents. As expected, obesity-related anthropometric markers positively correlated with IR and inflammatory markers while negatively correlated with adiponectin levels. CONCLUSIONS: Early IR, subclinical inflammation, dyslipidemia, and hypoadiponectinemia characterize obesity in adolescents. These factors may increase the risk of future coronary heart disease (CHD) and diabetes mellitus development (DM) in early adulthood.

2.
Clin Exp Immunol ; 131(2): 377-84, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12562402

RESUMEN

During the course of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), several immune and neuroendocrine changes associated with pregnancy may exert positive (amelioration) or negative (exacerbation) effects on the clinical outcome. In order to shed light on the mechanisms underlying these responses, we performed a prospective longitudinal study in RA and SLE pregnant women, including healthy pregnant women as a control group. Cytokine messenger RNA (mRNA) expression assessed by quantitative competitive polymerase chain reaction (PCR) in peripheral blood mononuclear cells (PBMC), cytokine levels and lymphocyte proliferation responses (LPR) following phytohaemagglutinin (PHA) stimulation of PBMC, plasma metalloprotease-9 activity (MMP-9) and hormonal status during pregnancy were determined. TNFa was the most abundant cytokine mRNA expressed in PBMC in all groups studied (healthy pregnant women, RA and SLE pregnant patients). However, a general TH2 response reflected by high IL-10 levels was found in RA, as well as SLE, patients. A significant change in IFN-gamma was observed in RA patients but only during the first trimester of pregnancy. This compared with a major TH1 response in healthy pregnant women. Interestingly, our study showed a homogeneous hormonal pattern in RA and SLE patients. Although decreased cortisol levels were observed in all patients studied, this is possibly related to the remission of disease activity status brought about by steroid treatment before and during pregnancy. In summary, we suggest that complex immune and hormonal networks are involved in pregnancy and that rheumatic diseases are very dynamic immune processes that cannot be described with a clear-cut cytokine profile. Furthermore, the observations in this study may reflect treatment-related immune effects more than those associated with disease.


Asunto(s)
Artritis Reumatoide/inmunología , Citocinas/sangre , Lupus Eritematoso Sistémico/inmunología , Metaloproteinasa 9 de la Matriz/sangre , Complicaciones del Embarazo/inmunología , Adulto , Artritis Reumatoide/sangre , Células Cultivadas , Citocinas/genética , Femenino , Expresión Génica , Hormonas/sangre , Humanos , Estudios Longitudinales , Lupus Eritematoso Sistémico/sangre , Activación de Linfocitos/inmunología , Reacción en Cadena de la Polimerasa/métodos , Embarazo , Complicaciones del Embarazo/sangre , Estudios Prospectivos , ARN Mensajero/genética , Células TH1/inmunología , Células Th2/inmunología
3.
J Med Virol ; 68(1): 24-32, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12210427

RESUMEN

The genotypes and subtypes of 15 Mexican hepatitis B virus strains were determined by sequencing and phylogenetic analysis of the small S-gene. The most predominant strains were found to be divergent genotype/subtype F/adw4 strains (66.6%), followed by A/adw2 (20.0%), D/ayw3 (6.7%), and G/adw2 (6.7%). The S-genes of the Mexican genotype F strains and two Nicaraguan strains described previously formed a subcluster with more than 4% divergence from the other strains within this genotype. The Mexican strains within genotypes A and D showed the highest homology with strains from Europe and the United States. Ten amino acid substitutions not described previously were found in the S-genes of strains from nine chronic carriers, whereas the S gene in strains from six acute hepatitis B patients were highly conserved as compared to their respective genotypes. One genotype F strain from an HBsAg positive chronic carrier had a T to A mutation at position 647, forming a translational stop at codon 216. Two genotype F strains from HBsAg negative chronic carriers had a Val180 instead of an Ala found in the other genotype F strains. This study shows that a divergent genotype F predominates in Mexican strains analyzed, which presented amino acid substitutions not reported previously outside the a determinant.


Asunto(s)
Variación Genética , Antígenos de Superficie de la Hepatitis B/genética , Hepatitis B/virología , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Secuencia de Bases , ADN Viral/análisis , Femenino , Genotipo , Virus de la Hepatitis B/clasificación , Virus de la Hepatitis B/genética , Humanos , Masculino , México , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa/métodos , Homología de Secuencia de Aminoácido
4.
J Ethnopharmacol ; 61(2): 143-52, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9683345

RESUMEN

The ethyl ether (EE) and hydroalcoholic extract (HE) of Magnolia grandiflora L. (Magnoliaceae) seeds, a popular plant utilized in the Mexican traditional medicine because of its antispasmodic as well as other reported pharmacological effects, were studied in adult male Wistar rats. EE and HE orally administered in a single dose of 250 mg/kg (calculated on lipidic base) and 200 mg/kg, exhibited abolition of the extensor reflex of maximal electric induced-seizure test in 50 and 40% of the experimental animals, respectively. They significantly prolonged the sleeping time induced by pentobarbital and only the ethanol extract induced hypothermia. No neurological deficit was exhibited by either extract according to the gait, stance and righting test. Although ulterior toxicological and pharmacological insight is necessary, these results suggest that the chemical constituents of this plant could have utility in the control of epileptic patients presenting convulsive seizures.


Asunto(s)
Anticonvulsivantes/farmacología , Plantas Medicinales/química , Animales , Anticonvulsivantes/toxicidad , Temperatura Corporal/efectos de los fármacos , Electrochoque , Etanol , Éter , Hipnóticos y Sedantes/farmacología , Masculino , Medicina Tradicional , México , Pentobarbital/farmacología , Extractos Vegetales/farmacología , Extractos Vegetales/toxicidad , Ratas , Ratas Wistar , Semillas/química , Convulsiones/prevención & control , Sueño/efectos de los fármacos , Solventes
5.
J Ethnopharmacol ; 45(3): 199-206, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7623484

RESUMEN

An aqueous extract of Casimiroa edulis leaves was tested in adult male Wistar rats for anticonvulsant activity utilizing two models of experimental epilepsy: maximal electroshock seizure (MES) and subcutaneously injected metrazole (METsc). Single dose of 100 mg/kg C. edulis vacuum dried aqueous extracts (VDA) orally administered to experimental animals elicited 50% and 70% abolition of MES and METsc-induced seizures, respectively. Two firmly established antiepileptic drugs in human therapy, phenytoin (PHT) and phenobarbital (PB), abolished 90% of MES-induced seizures, whereas an 80% and 100% absence of clonic seizures was attained in METsc test, correspondingly. The seizure abolition observed in C. edulis VDA treated rats was comparable with the anticonvulsive pattern exhibited by PHT and PB. These results suggest that potencially antiepileptic compounds are present in C. edulis extracts that deserve the study of their identity and mechanism of action.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Fenobarbital/uso terapéutico , Fenitoína/uso terapéutico , Extractos Vegetales/uso terapéutico , Convulsiones/tratamiento farmacológico , Administración Oral , Animales , Anticonvulsivantes/administración & dosificación , Modelos Animales de Enfermedad , Electrochoque , Inyecciones Subcutáneas , Masculino , México , Pentilenotetrazol/administración & dosificación , Pentilenotetrazol/toxicidad , Fenobarbital/administración & dosificación , Fenitoína/administración & dosificación , Extractos Vegetales/administración & dosificación , Hojas de la Planta , Ratas , Ratas Wistar , Convulsiones/inducido químicamente
6.
Arch Invest Med (Mex) ; 21(4): 339-47, 1990.
Artículo en Español | MEDLINE | ID: mdl-1669223

RESUMEN

Phenytoin and its vehicle were orally administered to adult Sprague-Dawley rats during 7, 14 and 30 days at doses of 300 and 450 mg/kg/24 hr., respectively. We found: 1) Increased liver DNA concentration in subgroups of animals treated with 450 mg at 7 (P < 0.02) and 15 days (P < 0.001) Phenytoin serum levels were 19 ug/ml. 2) Increased protein concentration with 300 mg at 7 (P < 0.01) and 15 days (P < 0.001), respectively. 3) Cloudy swelling, vacuolar degeneration, liver sinusoids disappearance and lymphocytic cells infiltrate in subgroups of rats receiving vehicle throughout 6, 14 and 15 days correspondingly. The former lesion was found in all subgroups, except that 450 mg treated animals liver more severely affected. 4) Increased DNA concentration in kidney of subgroups receiving 450 mg/kg throughout 7 (P < 0.05), 15 (P < 0.001) and 30 days (P < 0.001), correspondingly. 5) Increased protein concentration in rats receiving 450 mg during 15 days (P < 0.001) and severely decreased at 30 days period. 6) Cloudy swelling was found in all treated animals subgroups. Seven cellular and tissue lesions were caused by vehicle at 15 and 30 days periods. 450 mg of phenytoin predominantly caused tissue condensation and vacuolar degeneration in kidney cortex. 7) propylene glycol do affect liver and kidney at doses below TD-50. Phenytoin stimulate kidney and liver cell proliferation. Caution should be observed when using parenteral phenytoin.


Asunto(s)
Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Fenitoína/toxicidad , Administración Oral , Animales , División Celular/efectos de los fármacos , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , ADN/biosíntesis , Relación Dosis-Respuesta a Droga , Hígado Graso/inducido químicamente , Hígado Graso/patología , Femenino , Riñón/metabolismo , Riñón/patología , Enfermedades Renales/inducido químicamente , Enfermedades Renales/patología , Hígado/metabolismo , Hígado/patología , Masculino , Fenitoína/administración & dosificación , Fenitoína/farmacocinética , Propilenglicol , Glicoles de Propileno/toxicidad , Biosíntesis de Proteínas , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA